🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was designed to investigate the 1 year efficacy and safety of th...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-06
Trial ID
NCT00929110
Treatments Being Tested
The primary objective of this trial was to establish non-inferiority of lun...
Status
Completed
Location
Multiple Locations
Start Date
2005-07-28
Trial ID
NCT02242266
The purpose of this study is to evaluate, after 1 week of dosing, the effic...
Status
Completed
Location
Clinical Research of West Florida, Inc.
Start Date
2010-03
Trial ID
NCT01085045
The purpose of this study is to further figure out differences of glycopyrr...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-08
Trial ID
NCT01922271
Treatments Being Tested
This is a multiple dose, randomized, parallel, double-blind, double-dummy, ...
Status
Completed
Location
Research Site
Start Date
2016-07-05
Trial ID
NCT02796677
This study assessed the efficacy and safety of indacaterol (150 µg once dai...
Status
Completed
Location
Novartis Investigator Site
Start Date
2009-03
Trial ID
NCT00846586
Treatments Being Tested
Bioequivalence Study of Tiotropium Bromide Inhalation Powder 18 μg...
Status
Completed
Location
DownTown LA Research (West Coast)
Start Date
2022-08-17
Trial ID
NCT05986591
This study is designed to assess the effect of once-daily QVA149 on COPD ex...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-04
Trial ID
NCT01120691
Treatments Being Tested
This study has been designed to provide a substantial evidence of acute bro...
Status
Completed
Location
Unit of Preventive and Occupational Medicine - Laboratory of Respiratory Pathophysiology, University Hospital San Martino
Start Date
2010-04
Trial ID
NCT01112241
Treatments Being Tested
This study will evaluate the efficacy and safety of QVA149 (110/50 μg o.d.)...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-11-20
Trial ID
NCT02603393
Treatments Being Tested